Refine by
Cancer Related Lymphedema With Early Services
9 services found
Manufactured by:Grail, Inc. based inMenlo Park, CALIFORNIA (USA)
Development of a Blood Test with Prospective Study Cohort of 100,000 Participants. The STRIVE Study is a prospective, observational, longitudinal, cohort study that has enrolled approximately 100,000 women at the time of their screening mammogram. A subset of the data from STRIVE will be used to help validate GRAIL’s blood test for the early detection of multiple cancer types. Participants ...
Manufactured by:GENCURIX based inGuro-gu, SOUTH KOREA
Gencurix R&D Center is performing ceaseless research activities to developing the ‘multiplex assay’ which is core technology for economy in expenditures, time and samples. We have accumulated research capabilities and experiences of entire development process of molecular diagnostic ...
by:Envision Radiology based inColorado Springs, COLORADO (USA)
A mammogram procedure is simply an X-ray image of your breast. Mammography uses a low dose X-ray to look for early signs of breast cancer, such as lumps that are too small to be felt either by yourself or your healthcare provider. A mammogram can also show changes in your breast tissue which could indicate early-stage breast cancer. Our radiologists use digital mammogram imaging to both locate ...
Manufactured by:Grail, Inc. based inMenlo Park, CALIFORNIA (USA)
Assessing the Implementation of an Investigational Multi-Cancer Early Detection Test into Clinical Practice. The PATHFINDER Study is a prospective, multi-center study that will evaluate the implementation of GRAIL’s multi-cancer early detection test into clinical practice. GRAIL’s test is designed to detect and localize multiple types of cancer through a single blood draw, with a very ...
Manufactured by:Self-screen B.V. based inAmsterdam, NETHERLANDS
Self-screen is constantly developing novel state-of-the-art clinical tests for (early) cancer detection. These tests meet growing requirements in both primary screening as well as triage settings. This could be in terms of terms of validation of certain sample types, such as existing cytology preservatives, or other media, or for instance new sample types such as self sampling (validations for ...
by:Vigilant Biosciences, Inc. based inAustin, TEXAS (USA)
This year alone, oral cancer, including oral cancer, will affect the lives of hundreds of thousands of individuals and their families. ...
Manufactured by:Grail, Inc. based inMenlo Park, CALIFORNIA (USA)
Evaluation of a New Blood Test for Detecting Multiple Types of Cancer Early. The SUMMIT Study is a prospective, observational, longitudinal, cohort study being conducted in London in the United Kingdom. It is designed to enroll approximately 25,000 men and women age 50 to 77 years who do not have a cancer diagnosis at the time of enrollment. SUMMIT aims to further evaluate GRAIL’s blood ...
Manufactured by:ImCare Biotech, LLC based inDoylestown, PENNSYLVANIA (USA)
Overexpression of a novel apoptosis inhibitor, serine protease inhibitor Kazal (SPIK), has been demonstrated in HCC and other cancer patients. In addition, high levels of SPIK are closely associated with early recurrence in cancer patients following surgical resection. Because recurrence of cancer often implies the immune system’s inability to clear lingering oncogenic cells, early cancer ...
by:2M Engineering Ltd. based inValkenswaard, NETHERLANDS
Driving Innovation Through our comprehensive product creation services; At 2M, we are experts in creating cutting-edge smart sensing solutions that propel innovation in various industries. Our services encompass a wide range of offerings, from providing one-time consultancy or development projects to delivering full end-to-end product creation ...